Press release
Primary Biliary Cholangitis Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight
Key Takeaways from the Primary Biliary Cholangitis Market Research Report
* The increase in Primary Biliary Cholangitis Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
* As per DelveInsight analysis, the Primary Biliary Cholangitis Market is anticipated to witness growth at a considerable CAGR.
* The leading Primary Biliary Cholangitis Companies working in the market include Intercept Pharmaceuticals, CymaBay Therapeutics, Genfit, Genkyotex SA, Zydus Cadila, Cara Therapeutics, High Tide Therapeutics, Albireo, GlaxoSmithKline, and others.
* Promising Primary Biliary Cholangitis Therapies in the various stages of development include Seladelpar 10 mg, Saroglitazar Magnesium 1 mg, ASC42 5 mg, EDP-305 1 mg, Obeticholic Acid Tablets, K-808 (Dose A), and others.
* April 2024:- CymaBay Therapeutics- AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis. To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
* April 2024:- Gannex Pharma Co., Ltd.- A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis. This study is a phase II, multicenter, randomized, double-blind, placebo-controlled, seamless adaptive design clinical study, aiming to evaluate the safety and effectiveness of three doses of ASC42 matched placebo in subjects with primary biliary cholangitis.
Discover which therapies are expected to grab the Primary Biliary Cholangitis Market Share @ Primary Biliary Cholangitis Market Outlook [https://www.delveinsight.com/sample-request/primary-biliary-cholongitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Primary Biliary Cholangitis Overview
Primary Biliary Cholangitis (PBC) is a chronic liver disease characterized by the progressive destruction of small bile ducts within the liver. These ducts are responsible for transporting bile, a fluid that aids in the digestion of fats, from the liver to the small intestine. As the bile ducts become damaged and inflamed, bile builds up in the liver, leading to liver damage and scarring (cirrhosis).
Primary Biliary Cholangitis Epidemiology Insights
The epidemiology section of Primary Biliary Cholangitis offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Primary Biliary Cholangitis Epidemiology trends @ Primary Biliary Cholangitis Epidemiological Insights [https://www.delveinsight.com/sample-request/primary-biliary-cholongitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Primary Biliary Cholangitis Drugs Market
The Primary Biliary Cholangitis Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Primary Biliary Cholangitis signaling in Primary Biliary Cholangitis are likely to uncover new therapeutic targets and further expand treatment options for patients.
Primary Biliary Cholangitis Treatment Market Landscape
The Primary Biliary Cholangitis treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Primary Biliary Cholangitis has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Primary Biliary Cholangitis treatment guidelines, visit @ Primary Biliary Cholangitis Treatment Market Landscape [https://www.delveinsight.com/sample-request/primary-biliary-cholongitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Primary Biliary Cholangitis Market Outlook
The report's outlook on the Primary Biliary Cholangitis market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Primary Biliary Cholangitis therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Primary Biliary Cholangitis drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Primary Biliary Cholangitis market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.
Primary Biliary Cholangitis Drugs Uptake
The drug chapter of the Primary Biliary Cholangitis report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Primary Biliary Cholangitis.
Major Primary Biliary Cholangitis Companies
Several Primary Biliary Cholangitis Companies working in the market include Intercept Pharmaceuticals, CymaBay Therapeutics, Genfit, Genkyotex SA, Zydus Cadila, Cara Therapeutics, High Tide Therapeutics, Albireo, GlaxoSmithKline, and others.
Learn more about the FDA-approved drugs for Primary Biliary Cholangitis @ Drugs for Primary Biliary Cholangitis Treatment [https://www.delveinsight.com/sample-request/primary-biliary-cholongitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Primary Biliary Cholangitis Market Research Report
* Coverage- 7MM
* Primary Biliary Cholangitis Companies- Intercept Pharmaceuticals, CymaBay Therapeutics, Genfit, Genkyotex SA, Zydus Cadila, Cara Therapeutics, High Tide Therapeutics, Albireo, GlaxoSmithKline, and others.
* Primary Biliary Cholangitis Pipeline Therapies- Seladelpar 10 mg, Saroglitazar Magnesium 1 mg, ASC42 5 mg, EDP-305 1 mg, Obeticholic Acid Tablets, K-808 (Dose A), and others.
* Primary Biliary Cholangitis Market Dynamics: Primary Biliary Cholangitis Market Drivers and Barriers
* Primary Biliary Cholangitis Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Primary Biliary Cholangitis Drugs in development @ Primary Biliary Cholangitis Clinical Trials Assessment [https://www.delveinsight.com/sample-request/primary-biliary-cholongitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Executive Summary of Primary Biliary Cholangitis
3. Competitive Intelligence Analysis for Primary Biliary Cholangitis
4. Primary Biliary Cholangitis: Market Overview at a Glance
5. Primary Biliary Cholangitis: Disease Background and Overview
6. Patient Journey
7. Primary Biliary Cholangitis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Primary Biliary Cholangitis Unmet Needs
10. Key Endpoints of Primary Biliary Cholangitis Treatment
11. Primary Biliary Cholangitis Marketed Products
12. Primary Biliary Cholangitis Emerging Therapies
13. Primary Biliary Cholangitis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Primary Biliary Cholangitis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=primary-biliary-cholangitis-market-is-expected-to-showcase-a-significant-growth-at-a-cagr-of-x-by-2032-as-per-delveinsight]
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Biliary Cholangitis Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight here
News-ID: 3475572 • Views: …
More Releases from ABNewswire
Rug Hubb Celebrates Breakthrough Success in Social Media Engagement and Professi …
Innovative rug cleaning company sets a high bar in customer satisfaction and industry innovation.
Rug Hubb [http://www.rughubb.com/], a prominent provider of traditional hand washing for area rugs, coupled with captivating content creation surrounding the cleaning process, proudly announces another milestone achievement following its remarkable success in social media engagement.
Since its inception, Rug Hubb has distinguished itself by seamlessly intertwining superior rug cleaning services with an innovative approach to social media storytelling.…
Black Market Media's Epic Animated Film 'Garbage People: The Movie' Emerges Amid …
Garbage People: The Movie' continues the hit adult animation series 'Garbage People', taking on the dangers of AI and expanding the series' universe with adventure, sci-fi, and original music.
From creator Brit Tobin and Executive Producer Jeff Eastin (White Collar), Black Market Media announces the upcoming release of 'Garbage People: The Movie,' a feature-length continuation of the hit streaming adult-animation series 'Garbage People.' Building on the success of the show's first…
Eosinophilic Asthma Market Forecast 2032: Clinical Trials, Epidemiology, Therapi …
Eosinophilic Asthma companies are AstraZeneca, AB Science, Cheisi Pharmaceuticals, Teva Pharmaceuticals, Arteria Therapeutics, Knopp Biosciences, GlaxsoSmithKline, Novartis, And many others.
(Albany, USA) DelveInsight's "Eosinophilic Asthma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Eosinophilic Asthma, historical and forecasted epidemiology as well as the Eosinophilic Asthma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Eosinophilic Asthma market report provides current…
Maritime Patrol Aircraft Market Size worth $11.9 Billion by 2028, at a CAGR of 1 …
The global Maritime Patrol Aircraft Market in terms of revenue was estimated to be worth $6.7 billion in 2023 and is poised to reach $11.9 billion by 2028, growing at a CAGR of 12.1%% during the forecast period.
The report "Maritime Patrol Aircraft Market Size [https://www.marketsandmarkets.com/Market-Reports/maritime-patrol-aircraft-market-187686967.html] by Type (Armored, Unarmored), Propulsion System (Jet Engine, Electric Propulsion), Mode of Operation, Application, and Region (North America, Europe, Asia Pacific, Rest of the World…
More Releases for Primary
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…
Global Primary Sclerosing Cholangitis Market
The Primary Sclerosing Cholangitis report offers insights into vital aspects like growth,CAGR value, market share and revenue analysis. It evaluates the growth opportunities, threats, market drivers and risks involved. understand the market competition by analyzing the top vendors, with their market profile, revenue, profits, import-export details, and market share. it states the pricing structure, import-export details, supply chain analysis, SWOT analysis to facilitate the key decision-making process. This report helps…
Primary Lithium Battery (Primary Lithium Batteries) Industry Analysis by 2025: …
In its recently published report, QY Research has provided unique insights about global Primary Lithium Battery (Primary Lithium Batteries) market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments of the global Primary…
Primary Cells And Primary Batteries Market Analysis by Production Capacity, Dyna …
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Primary Cells And Primary Batteries market.
Description
The Global Primary Cells And Primary Batteries Market report offers a comprehensive evaluation of the Global Primary Cells And Primary Batteries industry. This report evaluates the Global market for " Global Primary Cells And Primary Batteries".
The Global Primary Cells…
Primary Immunodeficiency Diseases Market: Key Insights
With only a handful of companies enjoying the major share of the revenue pie, the global primary immunodeficiency diseases (PIDD) market exhibits a consolidated vendor landscape. As per Transparency Market Research (TMR), CSL Behring LLC and Grifols S.A. emerged dominant in the market with a share of 60.5% in 2014. Baxter International, Inc. and Octapharma AG are other prominent enterprises operating in the global PIDD market.
These companies have been…
Global Primary Biliary Cholangitis Treatment Market is Driven by Rise in Inciden …
Primary biliary cholangitis, previously known as primary biliary cirrhosis, is a rare chronic liver disease, primarily characterized by destruction of the bile ducts which transport bile acid out of the liver. Although the primary cause of the disease has not yet been elucidated, research across the world has attributed it to be autoimmune in nature. The progress of this disease results in the harmful accumulation of bile acid, which causes…
